Item no. |
PRS-33-394-100ug |
Manufacturer |
ProSci
|
Amount |
100 ug |
Category |
|
Type |
Antibody Monoclonal |
Format |
Liquid |
Applications |
WB, FC, IF |
Specific against |
Human, Monkey, Canine |
Host |
Mouse |
ECLASS 10.1 |
42030590 |
ECLASS 11.0 |
42030590 |
UNSPSC |
12352203 |
Available |
|
Shipping |
blue ice or RT |
By Research Area |
Immunology |
Immunogen |
Activated human peripheral blood mononuclear cells were used as the immunogen for the HLA-DRB1 antibody. |
Applications |
Flow Cytometry: 0.5-1 ug/million cells in 0.1ml
Immunofluorescence: 0.5-1 ug/ml
Optimal dilution of the HLA-DRB1 antibody should be determined by the researcher. |
Purification |
Protein G affinity chromatography |
Clonality |
Monoclonal |
Clone |
L243 |
Isotype |
IgG2a, kappa |
Conjugate |
Unconjugated |
Buffer |
PBS with 0.1 mg/ml BSA and 0.05% sodium azide |
Concentration |
0.2 mg/mL |
Storage Conditions |
Aliquot and Store at 2-8˚ C. Avoid freez-thaw cycles. |
Disclaimer |
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only. |
Modifications |
None |
Ncbi Official Symbol |
HLA-DRB1 |
Ncbi Gene Id # |
3123 |
User Note |
Optimal dilutions for each application to be determined by the researcher |
Ncbi Official Symbol |
HLA-DRB1 |
Ncbi Official Full Name |
major histocompatibility complex, class II, DR beta 1 |
Ncbi Organism |
Homo sapiens |
Swissprot # |
P01911 |
Background |
This mAb reacts with the HLA-DRB1 antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. It binds a conformational epitope on HLA-DR, which depends on the correct folding of the alpha/beta heterodimer. This mAb has been reported to block mixed lymphocyte reactions. The L243 antibody recognizes a different epitope than the LN3 monoclonal antibody, and these antibodies do not cross-block binding to each other's respective epitopes. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kD alpha (heavy) chain and a 28kD beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. |
1st Image Caption |
SDS-PAGE Analysis of Purified, BSA-Free HLA-DRB1 Antibody (clone L243). Confirmation of Integrity and Purity of the Antibody. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.